Tuberculosis : integrated studies for a complex disease / Nima Rezaei, editor.
Rezaei, Nima, editor.
2022
RC311
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Tuberculosis : integrated studies for a complex disease / Nima Rezaei, editor.
ISBN 9783031159558 (electronic bk.)
3031159551 (electronic bk.)
9783031159541
3031159543
DOI https://doi.org/10.1007/978-3-031-15955-8
Published Cham : Springer, 2022.
Language English
Description 1 online resource : illustrations (black and white).
Item Number 10.1007/978-3-031-15955-8 doi
Call Number RC311
Dewey Decimal Classification 616.99/5
Summary Tuberculosis have been documented since antiquity and the search of the microbes that cause this disease started more than three hundred years ago. Nevertheless, tuberculosis remains an important global health issue, with millions of people affected per year in addition to millions that remain undiagnosed and untreated. Patients with tuberculosis face the full range of recurrence, reinfection, and resistance due to diagnostic, prophylactic, and therapeutic procedures that are not as effective as they should be. In addition, variability in susceptibility to tuberculosis pose a complex problem with numerous interrelated variables. This volume is devoted to the understanding of Tuberculosis focusing on its heterogeneity, its transmission, manifestations, related conditions, diagnosis, treatments, drug resistance and prevention.
Note Includes index.
Access Note Access limited to authorized users.
Source of Description Description based on print version record.
Added Author Rezaei, Nima, editor.
Series Integrated science (Springer (Firm)) ; v. 11.
Available in Other Form Tuberculosis.
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
1. Introduction on Tuberculosis: Integrated Studies for a Complex Disease
2. Global Tuberculosis Epidemiology
3. Heterogeneity in Tuberculosis
4. The Unequivocal Relationship between Tuberculosis and Tobacco: Integration of Two Maladies
5. Relationship between Pre-existing Cancer and Tuberculosis
6. Laboratory Diagnosis of Tuberculosis
7. The Role of Diagnostic Microdevices in the Fight Against Tuberculosis
8. Immunodiagnostics of Tuberculosis: Recent Discoveries
9. Role of Bronchoscopy in Diagnostics and Treatment of Tuberculosis
10. Diagnosis of Childhood Tuberculosis in Low- and Middle-income Countries
11. Pediatric Tuberculosis: Current Evidence for Laboratory Diagnosis
12. A Multidisciplinary Approach Towards Finding and Treating All Tuberculosis Patients
13. Chemotherapy for Drug-Susceptible Tuberculosis
14. The Pharmacokinetic and Pharmacodynamic Properties of Antitubercular Medications
15. Immune Approaches In Tuberculosis Treatment
16. Inhalation Therapy in Pulmonary Tuberculosis
17. Role of Micronutrients in Tuberculosis Management
18. Drug Resistance in Tuberculosis: Mechanisms, Diagnosis, New Responses, and the Need for An Integrated Approach
19. Resistance in Tuberculosis: Molecular Mechanisms and Modulation
20. Personalized Tuberculosis Care for Drug-Resistant Tuberculosis
21. Important Targets and Inhibitors of Mycobacterium Tuberculosis
22. P-type ATPases: A Relevant Component in Mycobacterium tuberculosis Viability
23. The Challenges of Antitubercular Drug Discovery
24. Exploring Decaprenylphosphoryl
D-ribose 2-Epimerase 1 (DprE1): A Target for Anti-Tubercular Drugs
25. Energy Pathways in Mycobacterium Tuberculosis
26. Drug Discovery for Non-Tuberculous Mycobacteria: Recent Updates
27. Challenges for Contact Tracing and Tuberculosis Preventive Therapy Scale-up
28. Exploring Problematizations Underlying Tuberculosis Control Strategies: A Cross-Country Analysis of India and Kenya
29. Challenges in Prevention and Management of Tuberculosis
30. Tuberculosis in Contacts and Healthcare Workers
31. Tuberculosis Among People Who Use Drugs: Multilevel Considerations for Prevention, Diagnosis, and Treatment
32. Anti-Tumor Necrosis Factor- Antagonists and Tuberculosis
33. Breast Tuberculosis
34. Central Nervous System Tuberculosis: Pathogenesis, Diagnosis, and Management
35. Pleural Tuberculosis
36. Ocular Tuberculosis
37. Ocular Tuberculosis: Biomarkers for Risk Stratification
38. Bone and Joint Tuberculosis
39. Abdominal Tuberculosis: Pathogenesis, Clinical Features, and Diagnosis
40. Bovine Tuberculosis at The Interface of Cattle, Wildlife, and Humans
41. Evolution and Molecular Characteristics of Mycobacterium Tuberculosis and Mycobacterium Bovis
42. Animal Tuberculosis: Gross Lesions and Anatomopathological Diagnosis
43. Estimation of Microbial Mutation Rates in Tuberculosis Research
44. The Role of Epigenetics in the Development of Anti-Tuberculosis Drug Resistance
45. Multiomics Integration of Tuberculosis Pathogenesis
46. Lung Microbiome in Tuberculosis
47. The Correlation of Microbiota and Host Epigenome in Tuberculosis
48. The Pathogenesis and Progression of Sarcoidosis from The Standpoint of Tuberculosis
49. Tuberculosis: A Historical and Global Bioethical Perspective
50. The Problem of Tuberculosis: Myths, Stigma, and Mimics
51. Tuberculosis: Integrated Studies for a Complex Disease 2050.

Browse Subjects

Show more subjects...

Statistics

from
to
Export